Antibiotics--an investment worth making?

Area of Science:

• Pharmaceutical Sciences
• Infectious Diseases
• Drug Discovery

Background:

• The global antibiotics market represents a significant economic sector.
• There is a critical and growing need for new classes of antibiotics to combat resistant infections.
• Investor confidence in antibiotic development is currently low due to inherent risks.

Purpose of the Study:

• To analyze the current landscape of the antibiotics market.
• To identify the key risks associated with antibiotic development that deter investment.
• To explore potential strategies for mitigating these risks and encouraging investment in novel antibiotic classes.

Main Methods:

• Market analysis of the global antibiotics sector.
• Risk assessment of drug development pipelines for new antibiotic classes.
• Review of investment trends and barriers in antimicrobial research and development.

Main Results:

• The antibiotics market is economically vast, highlighting its importance.
• The urgent requirement for novel antimicrobial agents is well-established.
• Perceived risks in antibiotic research and development significantly impede investor engagement.

Conclusions:

• Despite the immense market potential and critical need, investment in new antibiotic classes is hampered by substantial risks.
• Overcoming these financial and developmental hurdles is essential for securing the future of antibiotic innovation.